BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 14758432)

  • 21. GAVI and the Vaccine Fund--a boon for immunization in the developing world.
    Balaji KA
    Indian J Public Health; 2004; 48(2):45-8. PubMed ID: 15709583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost of goods sold and total cost of delivery for oral and parenteral vaccine packaging formats.
    Sedita J; Perrella S; Morio M; Berbari M; Hsu JS; Saxon E; Jarrahian C; Rein-Weston A; Zehrung D
    Vaccine; 2018 Mar; 36(12):1700-1709. PubMed ID: 29449099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-dose vials versus single-dose vials for vaccination: perspectives from lower-middle income countries.
    Basu S; Rustagi R
    Hum Vaccin Immunother; 2022 Nov; 18(6):2059310. PubMed ID: 35416750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of wastage on single and multi-dose vaccine vials: Implications for introducing pneumococcal vaccines in developing countries.
    Parmar D; Baruwa EM; Zuber P; Kone S
    Hum Vaccin; 2010 Mar; 6(3):. PubMed ID: 20009517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Injection safety practice among health workers in static immunization centres in a Nigerian urban community.
    Musa OI
    Trop Doct; 2006 Jul; 36(3):185-6. PubMed ID: 16884637
    [No Abstract]   [Full Text] [Related]  

  • 26. [Microeconomic evaluation of a mass preventive immunisation campaign against meningococcal meningitis and yellow fever in Senegal in 1997].
    da Silva A; Parent du Châtelet I; Beckr Gaye A; Dompnier JP; Seck I
    Sante; 2003; 13(4):215-23. PubMed ID: 15047438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual-chamber injection device for measles-rubella vaccine: The potential impact of introducing varying sizes of the devices in 3 countries.
    Wedlock PT; Mitgang EA; Siegmund SS; DePasse J; Bakal J; Leonard J; Welling J; Brown ST; Lee BY
    Vaccine; 2018 Sep; 36(39):5879-5885. PubMed ID: 30146404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safer injections, fewer infections: injection safety in rural north India.
    Kermode M; Holmes W; Langkham B; Thomas MS; Gifford S
    Trop Med Int Health; 2005 May; 10(5):423-32. PubMed ID: 15860088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safe and newer injection technologies.
    Sharma S
    J Indian Med Assoc; 2005 Apr; 103(4):215-6, 218, 221. PubMed ID: 16173428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Injections--how safe.
    Sharma S
    J Indian Med Assoc; 2005 Apr; 103(4):210-1. PubMed ID: 16173426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Introducing multiple vaccines in low- and lower-middle-income countries: issues, opportunities and challenges.
    Gordon WS; Jones A; Wecker J
    Health Policy Plan; 2012 May; 27 Suppl 2():ii17-26. PubMed ID: 22513729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rotavirus vaccines: targeting the developing world.
    Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
    J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccine presentations and delivery technologies--what does the future hold?
    Clements CJ; Wesselingh SL
    Expert Rev Vaccines; 2005 Jun; 4(3):281-7. PubMed ID: 16026244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of immunization injection safety in China, 2010: achievements, future sustainability.
    Wu Z; Cui F; Chen Y; Miao N; Gong X; Luo H; Wang F; Zheng H; Kane M; Hadler SC; Hutin YJ; Liang X; Yang W
    Vaccine; 2013 Dec; 31 Suppl 9():J43-8. PubMed ID: 24331020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine wastage in The Gambia: a prospective observational study.
    Usuf E; Mackenzie G; Ceesay L; Sowe D; Kampmann B; Roca A
    BMC Public Health; 2018 Jul; 18(1):864. PubMed ID: 29996802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of a new combined vaccine in pediatric practices.
    Freed GL; Cowan AE; Clark SJ; Santoli J; Bradley J
    Pediatrics; 2006 Aug; 118(2):e251-7. PubMed ID: 16831895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccine presentation in the USA: economics of prefilled syringes versus multidose vials for influenza vaccination.
    Pereira CC; Bishai D
    Expert Rev Vaccines; 2010 Nov; 9(11):1343-9. PubMed ID: 21087111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variation in provider vaccine purchase prices and payer reimbursement.
    Freed GL; Cowan AE; Gregory S; Clark SJ
    Pediatrics; 2008 Dec; 122(6):1325-31. PubMed ID: 19047253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination vaccine use and vaccination quality in a managed care population.
    Happe LE; Lunacsek OE; Marshall GS; Lewis T; Spencer S
    Am J Manag Care; 2007 Sep; 13(9):506-12. PubMed ID: 17803364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.